Portugal

Bienvenue ! Sur cette page, vous trouverez toutes les dernières actualités juridiques, publications et événements pour Portugal. Pour rester informés des dernières évolutions, veuillez ajouter cette page à vos favoris sur votre mobile ou vous inscrire pour recevoir les eAlerts.

CMS est un acteur majeur en Portugal : pour en savoir plus, cliquez ici.

eAlerts Récentes

  •  
    19/07/2024
    EU

    Commission Delegated Regulation on sustainability disclosures for STS securitisations enters into force

    IntroductionThe Commission Delegated Regulation, supplementing Regulation (EU) 2017/2402 (the “Securitisation Regulation”[1]), entered into force on 8 July 2024 (the “Commission Delegated Regulation” [2]). It provides for regulatory technical standards (“RTS”) on the content, methodologies and presentation of information related to the principal adverse impacts of the assets financed by the underlying exposures on sustainability factors for (a) simple, transparent and standardised (“STS”) non-ABCP traditional securitisation, and for (b) STS on-balance-sheet...
    Lire la suite
  •  
    19/07/2024
    Europe

    La Commission européenne approuve une aide à la restructuration de 1,3 milliard EUR en faveur de SAS

    GB
    En octobre 2020, la Commission européenne a approuvé une mesure de recapitalisation d'environ 833 millions EUR, notifiée par la Suède et le Danemark, en faveur de SAS. Cette mesure était fondée sur l’Encadrement temporaire relatif aux aides d'État dans le contexte de la crise du COVID-19.Ryanair a introduit un recours à l’encontre de cette décision auprès du Tribunal de l’UE et obtenu son annulation en mai 2023. Fin 2022, SAS a entamé une procédure collective d'insolvabilité. Suite à...
    Lire la suite
  •  
    19/07/2024
    Europe

    A healthy balance between novelty and sufficiency for a claimed therapeutic use in view of a clinical trial disclosure in healthy volunteers (T 209/22)

    The question of novelty and sufficiency of second medical use claims in light of clinical trial prior art has been addressed by the EPO Boards of Appeal on a number of occasions. In recent decision T 209/22, the Appeal Board considers the impact of a disclosure relating to a clinical trial in healthy volunteers. The Appeal Board also comments on the different standards that apply for novelty and sufficiency of disclosure. The decision highlights that an attack based on novelty-sufficiency squeeze may not always be effective.BackgroundThe present decision relates to European patent 2506844 which...
    Lire la suite
  •  
    15/07/2024
    International

    CMS European Private Equity Study 2024

    We are pleased to share with you the 2024 edition of the CMS European Private Equity Study, a comprehensive analysis of hundreds of private equity deals CMS advised on across Europe in 2023 and previous years.Here are a few of the key findings:Deal activity remained stable despite economic challenges.New investments accounted for 69% of PE deals analysed; 50% were add-on acquisitions.TMT led sector activity at 24%, followed by Life Sciences and Consumer Products at 15% each.Earn-out provisions declined but stayed above pre-pandemic levels.ESG due diligence was conducted in 47% of PE deals.Arbitration...
    Lire la suite
  •  
    12/07/2024
    International

    Energy and climate change: The most significant (marine) climate change decision yet?

    Continuing the theme of a number of recent court judgment regarding state and party obligations concerning climate change issues, the International Tribunal for the Law of the Sea (“ITLOS”) has recently delivered its advisory opinion (the “Opinion”) regarding State obligations under the United Nations Convention on the Law of the Sea (“UNCLOS”) in relation to the prevention, reduction and control of pollution of the marine environment that result or are likely to result from climate change.The Opinion arrived only a few weeks following the ECtHR’s milestone...
    Lire la suite
  •  
    12/07/2024
    International

    EU’s AI Act published in Official Journal, transition periods now known

    Following the adoption of the "Regulation laying down harmonised rules on Artificial Intelligence" (AI Act) by the European Parliament and the Council of the European Union, this act was published in the Official Journal of the European Union on 12 July 2024. This marks the end of a long road of tough negotiations that began in 2021 with the European Commission's proposal for a Union-wide regulation on artificial intelligence (AI).The AI Act will enter into force on 1 August 2024. As a European regulation, it will apply directly in all 27 member states, but the AI Act provides for a graduated system...
    Lire la suite